CVD 37000: Immunity and Microbiome Studies at Intestinal and Systemic Sites in Ty21a Vaccinated Adults
NCT03970304
·
clinicaltrials.gov ↗
PHASE4
Phase
ACTIVE_NOT_RECRUITING
Status
87
Enrollment
OTHER
Sponsor class
Conditions
Typhoid Vaccination
Interventions
DRUG:
Vivotif Typhoid Oral Vaccine
Sponsor
University of Maryland, Baltimore